| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | ||
|---|---|---|---|---|---|
| AMAROQ | - | 5 | +10,26 % | ||
| FESTI | - | 4 | - | ||
| JBT MAREL | - | 2 | -0,97 % | ||
| ARION BANK | - | 1 | +0,16 % | ||
| ICELANDAIR GROUP HF | - | - | - | ||
| HAGAR | - | - | - | ||
| SKAGI | - | - | - | ||
| BRIM | - | - | - | ||
| REITIR | - | - | - |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | H.C. Wainwright bestätigt Oculis-Rating nach Beginn zulassungsrelevanter Studie | 2 | Investing.com Deutsch | ||
| Di | H.C. Wainwright reiterates Oculis stock rating on trial start | 2 | Investing.com | ||
| Di | KeyBanc initiates JBT Marel stock coverage with overweight rating | 2 | Investing.com | ||
| Di | Alvotech (ALVO) Gets New 'Buy' Reco. Should Investors Follow? | 9 | Insider Monkey | ||
| Mo | Alvotech advances 18%, accelerating post-earnings rally | 8 | Seeking Alpha | ||
| Mo | Kvika banki hf.: Transaction in relation to a share buy-back programme | 3 | GlobeNewswire (USA) | ||
| Mo | BofA startet Alvotech mit Kaufempfehlung dank Biosimilar-Plattform | 16 | Investing.com Deutsch | ||
| Mo | BofA initiates Alvotech stock with buy rating on biosimilar platform | 7 | Investing.com | ||
| Mo | Festi hf.: Transactions in relation to a share repurchase programme - week 34 | 7 | GlobeNewswire (USA) | ||
| Mo | Oculis Holding AG: First Patient Treated in PIONEER-1 Registrational Trial of Privosegtor for Optic Neuritis | 332 | GlobeNewswire (Europe) | The PIONEER program marks a key step toward potential first-in-class neuroprotection for optic neuritis and other neurological diseases, supported by positive Acuity Phase 2 data, FDA Breakthrough... ► Artikel lesen |